<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045759"><TermName>LY353381 hydrochloride</TermName><TermPronunciation>(... HY-droh-KLOR-ide)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of osteoporosis and breast cancer. LY353381 hydrochloride is made in the laboratory and binds to estrogen receptors in the body. It is a type of selective estrogen receptor modulator (SERM). Also called arzoxifene hydrochloride.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000707198" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;LY353381 hydrochloride&quot;" language="en" id="_3"/><MediaLink ref="CDR0000707199" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;clorhidrato de LY353381&quot;" language="es" id="_4"/><SpanishTermName>clorhidrato de LY353381</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de la osteoporosis y el cáncer de mama. El clorhidrato de LY353381 se produce en el laboratorio; se une a los receptores de estrógeno del cuerpo. Es un tipo de modulador selectivo del receptor de estrógenos (MSRE). También se llama clorhidrato de arzoxifeno.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-03-31</DateLastModified></GlossaryTerm>
